FibroTest™ simply involves taking a blood sample from your usual medical test laboratory.
FibroTest evaluates hepatic fibrosis into five stages: from F0 (healthy liver) to F4 (cirrhosis).
In most cases, FibroTest acts as a replacement for a liver biopsy.
The tests target the four main causes of liver disease: fibrosis/cirrhosis (FibroTest™), inflammation (ActiTest™, NashTest™ 2), metabolic conditions (SteatoTest™ 2) and alcohol-related conditions (AshTest™).
NASH-FibroTest™ combines FibroTest, SteatoTest 2 and NashTest 2 along with ActiTest and AshTest into a single blood sample, for patients at risk of NAFLD (Non-Alcoholic Fatty Liver Disease) with or without comorbidities (due to excessive alcohol consumption and hepatitis).